Teva Pharmaceutical Industries Limited Cash Flow Reinvestment Rate
Teva Pharmaceutical Industries Limited cash flow reinvestment rate. Teva Pharmaceutical Industries Limited (TEV) has a Cash Flow Reinvestment Rate of 0.14x as of December 2025, reinvesting €167.00 Million (capex €142.00 Million plus investments €25.00 Million) from operating cash flow of €1.16 Billion. Explore Teva Pharmaceutical Industries Limited cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Teva Pharmaceutical Industries Limited (2015–2025)
Cash flow reinvestment rate of Teva Pharmaceutical Industries Limited from 2015 to 2025. Historical reinvestment intensity for Teva Pharmaceutical Industries Limited across 11 annual periods. Explore TEV capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Teva Pharmaceutical Industries Limited Cash Flow Reinvestment Rate by Year (2015–2025)
Teva Pharmaceutical Industries Limited cash flow reinvestment rate by year from 2015 to 2025. Year-by-year capital reinvestment analysis for Teva Pharmaceutical Industries Limited. For the full cash flow conversion analysis, see Teva Pharmaceutical Industries Limited cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.31x | €516.00 Million | €1.65 Billion | €501.00 Million | ▼ -26.2% |
| 2024 | 0.42x | €529.00 Million | €1.25 Billion | €498.00 Million | ▼ -64.5% |
| 2023 | 1.20x | €1.38 Billion | €1.16 Billion | €549.00 Million | ▲ +245.2% |
| 2022 | 0.35x | €551.00 Million | €1.59 Billion | €548.00 Million | ▼ -59.7% |
| 2021 | 0.86x | €687.00 Million | €798.00 Million | €562.00 Million | ▲ +68.6% |
| 2020 | 0.51x | €621.00 Million | €1.22 Billion | €578.00 Million | ▼ -28.1% |
| 2019 | 0.71x | €531.00 Million | €748.00 Million | €525.00 Million | ▲ +125.5% |
| 2018 | 0.31x | €770.00 Million | €2.45 Billion | €651.00 Million | ▼ -34.8% |
| 2017 | 0.48x | €1.07 Billion | €2.23 Billion | €874.00 Million | ▼ -94.9% |
| 2016 | 9.42x | €36.64 Billion | €3.89 Billion | €901.00 Million | ▲ +1781.1% |
| 2015 | 0.50x | €2.77 Billion | €5.54 Billion | €772.00 Million | — |